Toronto, Canada (PRWEB) June 04, 2013
The ability to ensure that relevant and accurate laboratory testing is performed is the basic expectation for any central laboratory. To optimally employ the myriad of laboratory resources available to perform seemingly identical tests, a rigorous scientific review is an essential component of clinical trials protocol design.
An important step is a thorough review by experienced personnel versed in the scientific/technical and operational aspects of indication-specific laboratory testing. Additional considerations include the level of experience the laboratory has with performing testing for specific indications; how the laboratorys current test menu aligns with the protocol requirements and the willingness of the laboratory to tailor innovative solutions to meet unique endpoints.
Attendees of this webinar will acquire a solid understanding of:
This webinar is part of ACM Globals Navigating Global Clinical Trials with your Central Lab series of informative and interactive events.
To learn more about the event, visit: http://www.xtalks.com/Endpoint-Based-Protocol-Development.ashx
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.
Contact: Karen Lim (416) 977-6555 ext 227 clientservices(at)xtalks(dot)com
Read the original here:
Endpoint Based Protocol Development: A Central Laboratory Perspective + Microbiology Case Study, New Life Science ...